Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients

2010 ◽  
Vol 77 (2) ◽  
pp. 260-267 ◽  
Author(s):  
Wail Al-Kashkari ◽  
Prakash Balan ◽  
Clifford J. Kavinsky ◽  
Qi-Ling Cao ◽  
Ziyad M. Hijazi
Keyword(s):  
Adult Patients ◽  
Ventricular Septal Defects ◽  
Device Closure ◽  
Septal Defects ◽  
Percutaneous Device ◽  
Percutaneous Device Closure

Echocardiography-guided transcatheter closure of perimembranous ventricular septal defects without arterial access:a fluoroscopy-free technique for alternative use in children

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
H Bu ◽  
Y Yang ◽  
Q Wu ◽  
W Zhang ◽  
S Hu ◽  
...  
Keyword(s):  
Radiation Exposure ◽  
Femoral Vein ◽  
Ventricular Septal Defects ◽  
Device Closure ◽  
Residual Shunt ◽  
Surgical Incision ◽  
Septal Defects ◽  
Arterial Complications ◽  
Percutaneous Device ◽  
Percutaneous Device Closure

Abstract Background Traditional percutaneous device closure of perimembranous ventricular septal defects (PmVSDs) is a minimally invasive technique, but can result in high radiation exposure and potential arterial complications. The feasibility of another alternative surgical repair technique for closure of VSDs by percardiac device has been proven. However, the disadvantages of surgical trauma and incision in the inferior sternum cannot avoid. Purpose In an effort to avoid radiation exposure, arterial access, surgical incision and complications, we established a novel technique for transcatheter VSD closure via the femoral vein approach under the guidance of transesophageal echocardiography (TEE) without fluoroscopy. And the feasibility and safety of this new strategy have been assessed. Methods From January 2015 to June 2019, a total of 48 PmVSD patients (mean age, 7.5±2.4 years [range, 4.3– 12.0 years]; mean body weight 24.6±6.8 kg [range, 16.5–38.5 kg]; VSD diameter, 4.3±0.6 mm [range, 3.2–5.0 mm]) underwent attempted transcatheter closure via the femoral vein approach under the guidance of TEE without fluoroscopy. Results The transcatheter occlusion procedure under TEE guidance was successful in 46 (95.8%) patients. Surgery was necessary in 2 (4.2%) patients. The mean procedural duration, post-operative mechanical ventilation duration, intensive care unit (ICU) residence, and in-hospital durations were 27.2±7.4 min (range, 12.0–42.0 min), 63.2±5.3 min (range, 56.0–78.0 min), 2.1±0.1 h (mean, 2.0–2.4 h), and 2.7±0.3 d (range, 2.5–3.0 d), respectively. One patient had immediate post-operative trivial residual shunt and four patients had immediate incomplete right bundle branch block (IRBBB) after operation; the new IRBBB in 2 cases were noted in the first postoperative month. No residual shunt was noted at 3 months after the procedure, and no intervention related complications were detected at 1–36 months follow-up. Conclusion Echocardiography-guided percutaneous device closure of PmVSDs solely by femoral vein approach is effective and safe, avoids radiation exposure, potential arterial complications and a surgical incision. Procedure of percutaneous closure PmVSD Funding Acknowledgement Type of funding source: Foundation. Main funding source(s): The Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.

scholarly journals Percutaneous Device Closure of Congenital Isolated Ventricular Septal Defects: A Single-Center Retrospective Database Study Amongst 412 Cases

2020 ◽  
Vol 41 (3) ◽  
pp. 591-598 ◽  
Author(s):  
Varsha Walavalkar ◽  
Shreesha Maiya ◽  
Suresh Pujar ◽  
Prakash Ramachandra ◽  
Satheesh Siddaiah ◽  
...  
Keyword(s):  
Single Center ◽  
Ventricular Septal Defects ◽  
Device Closure ◽  
Database Study ◽  
Septal Defects ◽  
Percutaneous Device ◽  
Percutaneous Device Closure ◽  
Retrospective Database

Transcatheter closure of ventricular septal defects in children less than 10 kg: experience from a tertiary care referral hospital in Eastern India

2021 ◽  
pp. 1-7
Author(s):  
Mahua Roy ◽  
Debasree Gangopadhyay ◽  
Noopur Goyal ◽  
Savita Murthy ◽  
Debabrata Nandi ◽  
...  
Keyword(s):  
Ventricular Septal Defect ◽  
Septal Defect ◽  
Ventricular Septal Defects ◽  
Device Closure ◽  
Small Children ◽  
Surgical Closure ◽  
Septal Defects ◽  
Percutaneous Device ◽  
Transcatheter Device ◽  
Percutaneous Device Closure

Abstract Objective: To assess the feasibility of percutaneous transcatheter device closure of ventricular septal defects in children weighing less than 10 kg. Background: Although percutaneous transcatheter device closure of ventricular septal defect is a well-established method of treatment in older children and adolescents, there is limited data on device closure in small children weighing less than 10 kg. We present our institutional experience of transcatheter VSD closure in children weighing less than 10 kg. Method: Medical records were reviewed for 16 children, who were selected for device closure of ventricular septal defects based on the inclusion criteria. Results: Out of 65 patients with a diagnosis of ventricular septal defect, 16 children less than 10 kg were attempted for percutaneous device closure. In 13 patients, the device was successfully released, and 3 patients needed surgical closure of the defect. Mean age and weight of the patients were 17.3 ± 12.7 months and 6.8 ± 3.2 kg, respectively. Mean defect size was 6 mm (range 3–10). There was no incidence of device embolisation or heart block or death. Five patients had residual left-to-right shunt immediately after the device release, which got closed by the first month’s follow-up. We had one accidental perforation of right ventricular free wall at the time of crossing of the defect, which was successfully repaired surgically. Conclusion: Percutaneous device closure of ventricular septal defect in small children with weight below 10 kg is feasible with good short-term outcome. Careful patient selection is essential for procedural success and to avoid complications.

scholarly journals Asymptomatic Embolization After Percutaneous Ostium Primum Atrial Septal Defect Closure: a Rare Complication

2019 ◽  
Vol 1 (2) ◽  
pp. 8-13
Author(s):  
Sergiu Vijiala ◽  
Eric Eeckhout ◽  
Grégoire Girod ◽  
Grégoire Girod
Keyword(s):  
Rare Complication ◽  
Ventricular Outflow Tract ◽  
Left Ventricular ◽  
Device Closure ◽  
Atrial Septal Defect Closure ◽  
Septal Defects ◽  
Percutaneous Device ◽  
Left Ventricular Outflow ◽  
Device Embolization ◽  
Percutaneous Device Closure

Percutaneous device closure of atrial septal defects (ASD) has proven to be safe and it is nowadays the standard treatment for ASDs. Immediate or late device embolization is a rare but potential complication of every attempted ASD device closure. We report a case of asymptomatic Amplatzer Septal Occluder into the left ventricular outflow tract (LVOT) detected by routine transthoracic echocardiography 3 months after successful implantation in a stable patient.

scholarly journals The midterm effect of exercise capacity and quality of life in adult patients who underwent hybrid transthoracic device closure of ventricular septal defects

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Qiang Chen ◽  
Rong Yang ◽  
Yu-Qing Lei ◽  
Kai-Peng Sun ◽  
Hua Cao
Keyword(s):  
Quality Of Life ◽  
Exercise Capacity ◽  
Left Ventricular ◽  
Healthy People ◽  
Adult Patients ◽  
Ventricular Septal Defects ◽  
Device Closure ◽  
Septal Defects ◽  
The Difference

Abstract Objective To investigate the midterm effect of exercise capacity and quality of life (QoL) of adult patients who underwent transthoracic device closure of ventricular septal defects (VSDs) and explore the gap in the quality of life and cardiopulmonary function between those patients and healthy people. Methods From January 2010 to January 2015, 58 adult patients who underwent transthoracic device closure of VSD and 60 healthy people matched for age and sex were selected and analyzed. Echocardiography and exercise capacity tests were performed, and the MOS 36-item short-form health survey (SF-36) was used to investigate the changes in QoL. Results Fifty-five patients completed the study. At the 1-year and 5-year follow-ups, the patients’ left ventricular end-systolic and end-diastolic diameters were smaller than those preoperatively, but the difference was not statistically significant. In the QoL survey, the patients’ scores after treatment showed a trend of improvement, and the improvement effect was not transient. After VSD closure, the difference in QoL between the patients and the control group was significantly reduced. However, in the exercise capacity test, the patients’ results were still worse than those of the controls. Conclusion Transthoracic device closure of VSDs is significant in improving adult patients’ QoL at the midterm follow-up, reflected in their physical and psychological fields. However, they are still unable to achieve normal levels of peak exercise ability. Therefore, further exploration and interventions are worth considering.

scholarly journals Atrial tachyarrhythmias following percutaneous device closure of secundum atrial septal defects

2020 ◽  
Vol 27 ◽  
pp. 100490
Author(s):  
Vishal Vyas ◽  
Amit Kaura ◽  
Vinit Sawhney ◽  
Martin Lowe ◽  
Vivienne Ezzat
Keyword(s):  
Device Closure ◽  
Atrial Tachyarrhythmias ◽  
Septal Defects ◽  
Atrial Septal Defects ◽  
Percutaneous Device ◽  
Percutaneous Device Closure
Sign in / Sign up

Export Citation Format

Share Document